Search

Design Therapeutics Inc

Gesloten

15.11 1.48

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

14.63

Max

15.44

Belangrijke statistieken

By Trading Economics

Inkomsten

-2.5M

-20M

EPS

-0.32

Werknemers

55

EBITDA

-4.5M

-22M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+64.84% upside

Dividenden

By Acuity

Volgende Winsten

3 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

203M

945M

Vorige openingsprijs

13.63

Vorige sluitingsprijs

15.11

Design Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 aug 2026, 23:51 UTC

Mixed trading in European equities amid rising geopolitical tensions and anticipation of key U.S. economic data releases, with investors eyeing potential impacts from new Iran sanctions and upcoming Jackson Hole Symposium insights.

24 aug 2026, 23:51 UTC

US equity indices remain flat as investors await key economic data and corporate earnings, while geopolitical tensions and rising oil prices add to inflation concerns.

24 aug 2026, 23:51 UTC

Global equity markets show mixed performance as U.S. investors await key earnings and economic data amid signs of below-trend growth.

24 aug 2026, 23:51 UTC

Asia equity markets decline as investors brace for Nvidia earnings and U.S. inflation data amid rising oil prices and geopolitical tensions.

24 aug 2026, 23:51 UTC

Germany's Upcoming Inflation Rate Release Sparks Caution Among Market Participants Amid Global Economic Uncertainty

24 aug 2026, 23:51 UTC

Germany's Upcoming Inflation Rate Release Sparks Caution Amid Global Economic Pressures and Potential ECB Policy Implications.

24 aug 2026, 23:51 UTC

U.S. Initial Jobless Claims Report Forecasts 208,000 Amid Positive Labor Market Sentiment Ahead of August Release

24 aug 2026, 23:51 UTC

Mixed signals in U.S. housing market as analysts forecast July new home sales at 620,000 units amid declining Texas activity and rising inventory concerns.

24 aug 2026, 23:51 UTC

Cautious Market Sentiment Ahead of U.S. New Home Sales Data Release Amid Declining Trends

24 aug 2026, 23:51 UTC

Japan's Capital Spending YoY data release on August 31, 2026, may reflect increased private investment driven by government tax incentives and AI initiatives.

24 aug 2026, 23:46 UTC

Trex Company Inc. shares are near unchanged in after-market trading, reflecting stability amid broader market conditions with no specific news identified.

24 aug 2026, 23:46 UTC

Correlated Moves

Terex Corp shares are trading lower in after-market hours, reflecting broader market trends and ongoing macroeconomic concerns affecting small-cap stocks.

24 aug 2026, 23:46 UTC

Correlated Moves

OneMain Holdings Inc shows slight gains in after-market trading, following minor fluctuations during the regular session. The stock remains below its 20-day moving average.

24 aug 2026, 23:46 UTC

Las Vegas Sands shares are higher in after-market hours, reflecting a modest gain since Monday's close amid routine trading and no specific news identified.

24 aug 2026, 23:46 UTC

Kite Realty Group Trust traded roughly flat in after-market hours, remaining about 3.01% below its 20-day moving average.

24 aug 2026, 23:46 UTC

St. Joe Co. shares were roughly flat during after-market hours, maintaining a position above the 20-day moving average despite earlier fluctuations.

24 aug 2026, 23:46 UTC

Evertec Inc. shares showed routine trading activity after-market hours, remaining roughly flat since Monday's close with no specific news identified.

24 aug 2026, 23:46 UTC

Equifax Inc shares rose during after-market hours, reflecting routine trading activity. The stock remains positioned above its 20-day moving average amid no specific news.

24 aug 2026, 23:46 UTC

Daily Journal Corp shares are lower in after-market hours, despite trading above their 20-day moving average and near the upper end of their one-month range.

24 aug 2026, 23:46 UTC

Correlated Moves

Howmet Aerospace Inc shares are higher in after-market trading, supported by gains in the aerospace and defense sector, despite remaining below their 20-day moving average.

24 aug 2026, 23:46 UTC

Cal-Maine Foods Inc. is trading higher in after-market hours, reflecting a steady upward trajectory since Monday's close. No specific news was identified.

24 aug 2026, 23:46 UTC

Visteon Corp. shares were roughly flat in after-market hours, remaining below their 20-day moving average and near the lower end of their one-month range.

24 aug 2026, 23:46 UTC

Oceaneering International Inc. shares are higher in after-hours trading, maintaining a position above the 20-day moving average amid no specific news.

24 aug 2026, 23:46 UTC

Shares of Fortinet Inc. are higher in after-market trading, though they remain below their 20-day moving average and near the lower end of their one-month range.

24 aug 2026, 23:46 UTC

Edison International shares traded lower in after-market hours, reflecting fluctuations while remaining above the 20-day moving average. No specific news was identified.

24 aug 2026, 23:46 UTC

Old Dominion Freight Line Inc. shares are higher in after-market trading, reflecting routine performance despite remaining below the 20-day moving average.

24 aug 2026, 23:46 UTC

Monro Inc. shares were roughly flat in after-market trading. The stock has declined significantly compared to the month-ago close.

24 aug 2026, 23:46 UTC

Matthews International Corp shares were modestly higher during after-market hours, despite remaining below their 20-day moving average and facing a recent decline.

24 aug 2026, 23:46 UTC

Geron Corp shares are higher in after-market trading, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

24 aug 2026, 23:46 UTC

News

PG&E Corp shares are lower in after-market hours despite announcing an expansion of its Vehicle to Everything program and analysts' fair value estimate of $22.59.

Peer Vergelijking

Prijswijziging

Design Therapeutics Inc Prognose

Koersdoel

By TipRanks

64.84% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 24.71 USD  64.84%

Hoogste 40.54 USD

Laagste 20 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Design Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.
help-icon Live chat